Future Industry's Largest Shareholder Nexten Bio Participates in Shareholder Priority Rights Offering... "Strengthening Management Rights and Commitment to Responsible Management"

Mirae Industry, a semiconductor post-processing specialist company (CEO Changjae Lee), announced on the 20th that Nexton Bioscience (CEO Jeongchan Lee), the largest shareholder, has completed the subscription and payment for all 3,546,153 shares allocated in the shareholder priority rights offering.

A representative of Nexton Bioscience stated, "The number of shares increased from 2,906,508 to 6,452,661, demonstrating the intention to strengthen management rights and responsible management as the largest shareholder."

A representative of Mirae Industry said, "The largest shareholder completed the full subscription and payment to show their intention to strengthen management rights and responsible management to other shareholders. The funds raised this time will be used for facility investment," adding, "Achieving consolidated sales of 17.2 billion KRW and operating profit of 8.2 billion KRW by the third quarter of this year is based on the monetization of previously secured order backlogs and the expansion of new orders such as from Infineon in Germany. Through this capital increase, we will strive to enhance shareholder value based on maximizing corporate value and increasing sales and profits."